On Nov 2, 2021 Infusion for Health closed a Venture – Series Unknown round and raised $50,000,000 from Cimarron Healthcare Capital, Oak HC/FT, featuring lead […]
Series B – Biolinq
On Nov 2, 2021 Biolinq closed a Series B round and raised $100,000,000 from Able Partners, Aphelion Capital, Ascensia Diabetes Care, AXA Investment Managers, Cirrus […]
Seed Round – Avelios Medical
On Nov 2, 2021 Avelios Medical closed a Seed round and raised €2,000,000 from Revent, featuring lead investors Revent. About the company: Avelios Medical is […]
Series B – New View Surgical
On Nov 2, 2021 New View Surgical closed a Series B round and raised $9,000,000 from Ariel Savannah Angel Partners, Charleston Angel Partners, Corza Medical, […]
Series D – Cambridge Epigenetix
On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Series B – Violet Defense
On Nov 2, 2021 Violet Defense closed a Series B round and raised $20,000,000 from Katalyst Securities, Kirenaga Partners, featuring lead investors Katalyst Securities, Kirenaga […]
Series C – Lightforce Orthodontics
On Nov 2, 2021 Lightforce Orthodontics closed a Series C round and raised $50,000,000 from AM Ventures, Kleiner Perkins, Matrix Partners, Tyche Partners, featuring lead […]
Venture Round – Shoreline Biosciences
On Nov 2, 2021 Shoreline Biosciences closed a Venture – Series Unknown round and raised $140,000,000 from Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, […]
Grant – InterveXion Therapeutics
On Nov 1, 2021 InterveXion Therapeutics closed a Grant round and raised $13,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
Post-IPO Equity – Valneva
On Nov 1, 2021 Valneva closed a Post-IPO Equity round and raised €88,000,000 from investors, featuring lead investors . About the company: Valneva is located […]
